Maviret

Medicinal product

(Invented) name

Maviret

Active substance (s)

Glekapreviras/Pibrentasviras

Strength

100 mg/40 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J05AP57, Glecaprevir and pibrentasvir

Marketing authorisation holder

AbbVie Deutschland GmbH & Co. KG , Vokietija

Date of authorisation

2017-07-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Glekapreviras	100 mg
Pibrentasviras	40 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
97562	83656	1083656	lizdinė plokštelė	N84 (4x21)		Receptinis	EU/1/17/1213/001	Tiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2017-07-26	Registruotas